Advertisement
Research ArticleArticle

Functional Selectivity in CB2 Cannabinoid Receptor Signaling and Regulation: Implications for the Therapeutic Potential of CB2 Ligands

Brady K. Atwood, James Wager-Miller, Christopher Haskins, Alex Straiker and Ken Mackie
Molecular Pharmacology February 2012, 81 (2) 250-263; DOI: https://doi.org/10.1124/mol.111.074013

Article Information

vol. 81 no. 2 250-263
DOI 
https://doi.org/10.1124/mol.111.074013
PubMed 
22064678
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received June 8, 2011
  • Accepted November 7, 2011
  • Published online January 17, 2012.

Article Versions

Copyright & Usage 
Copyright © 2012 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Brady K. Atwood,
  2. James Wager-Miller,
  3. Christopher Haskins,
  4. Alex Straiker and
  5. Ken Mackie
  1. Department of Psychological and Brain Sciences, Gill Center for Biomolecular Science, Indiana University, Bloomington, Indiana (B.K.A., J.W.-M., C.H., A.S., K.M.)
  1. Address correspondence to:
    Ken Mackie, Department of Psychological and Brain Sciences, Indiana University, 1101 E. 10th Street, Bloomington, IN 47405. E-mail: kmackie{at}indiana.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: November 2011 to February 2021

AbstractFullPdf
Nov 20112920247
Dec 201184073
Jan 201235038127
Feb 20122764673
Mar 20121633244
Apr 20121373051
May 2012814543
Jun 2012521920
Jul 2012662438
Aug 2012352620
Sep 2012474753
Oct 2012843251
Nov 2012582840
Dec 20121351226
Jan 2013902733
Feb 2013561745
Mar 2013613457
Apr 2013794449
May 2013441536
Jun 2013301821
Jul 2013342628
Aug 2013162621
Sep 2013412521
Oct 2013381826
Nov 2013451423
Dec 201335815
Jan 2014151220
Feb 2014191222
Mar 2014271548
Apr 201422623
May 2014182639
Jun 2014232019
Jul 2014171716
Aug 2014211721
Sep 2014232619
Oct 2014243725
Nov 2014182111
Dec 2014221615
Jan 2015523314
Feb 2015201911
Mar 2015512821
Apr 2015221814
May 2015171412
Jun 2015432414
Jul 2015241627
Aug 2015212515
Sep 2015331514
Oct 2015221113
Nov 201518615
Dec 2015282513
Jan 201617715
Feb 2016272632
Mar 201618919
Apr 201625823
May 2016191218
Jun 2016251125
Jul 20164822
Aug 201614830
Sep 201692423
Oct 201681514
Nov 201692821
Dec 201641817
Jan 2017133119
Feb 20171197
Mar 2017102728
Apr 2017122525
May 20177197
Jun 20174175
Jul 201791613
Aug 201752714
Sep 20174259
Oct 201710305
Nov 2017124329
Dec 201713289
Jan 201862818
Feb 2018152410
Mar 2018132121
Apr 201842014
May 20186258
Jun 201873113
Jul 201811612
Aug 201832913
Sep 201841514
Oct 20183198
Nov 201892222
Dec 20183096
Jan 20192989
Feb 201940812
Mar 2019181021
Apr 201927511
May 20193176
Jun 201916312
Jul 201926618
Aug 20194485
Sep 20192387
Oct 20194179
Nov 20191786
Dec 20192486
Jan 20202146
Feb 20202535
Mar 20203365
Apr 20201998
May 20203285
Jun 202036512
Jul 202025118
Aug 20201034
Sep 20201985
Oct 20204778
Nov 20201624
Dec 20204442
Jan 202128128
Feb 20211782

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Research ArticleArticle

Functionally Selective CB2 Ligands

Brady K. Atwood, James Wager-Miller, Christopher Haskins, Alex Straiker and Ken Mackie
Molecular Pharmacology February 1, 2012, 81 (2) 250-263; DOI: https://doi.org/10.1124/mol.111.074013
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section